Lack of galectin-3 modifies differentially Notch ligands in bone marrow and spleen stromal cells interfering with B cell differentiation
Felipe Leite de Oliveira(Universidade Federal do Rio de Janeiro), Márcia C. El-Cheikh(Universidade Federal do Rio de Janeiro), Marise Lopes Fermino(Universidade de São Paulo), Emerson Soares Bernardes(Nuclear Engineering Institute), Camila Brand(Universidade Federal do Rio de Janeiro), Lauremília Ricon(Universidade Federal do Rio de Janeiro), Roger Chammas(Universidade de São Paulo), Thayse Pinheiro da Costa(Universidade Federal do Rio de Janeiro), Sofia Nascimento dos Santos(Instituto de Pesquisas Energéticas e Nucleares), Jonathas Xavier Pereira(Universidade Federal do Rio de Janeiro)
Cited by 25
Related Papers
Toxoplasma gondii Infection Reveals a Novel Regulatory Role for Galectin-3 in the Interface of Innate and Adaptive Immunity
|American Journal Of Pathology|2006|142
MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications
|Nanomedicine Nanotechnology Biology and Medicine|2017|108
LPS-Induced Galectin-3 Oligomerization Results in Enhancement of Neutrophil Activation
|PLoS ONE|2011|85
Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation
|Oncotarget|2017|82
Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii
|Microbes and Infection|2006|75